v3.25.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 3,040 $ 13,199
Marketable securities 83,970 82,376
Total Current Assets 87,010 95,575
Total Assets 87,010 95,575
Current Liabilities    
Accounts payable and accrued expenses 723,144 780,148
Convertible note payable, net of debt discount of $0 and $0, as of March 31, 2025 and December 31, 2024 500,000 500,000
Total Current Liabilities 5,164,522 5,166,681
Total Liabilities 5,164,522 5,166,681
Stockholders’ Deficit    
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of  March 31, 2025 and December 31, 2024, respectively 2,167 2,167
Additional paid-in capital 810,048 810,048
Accumulated deficit (5,889,727) (5,883,321)
Total Stockholders’ Deficit (5,077,512) (5,071,106)
Total Liabilities and Stockholders’ Deficit 87,010 95,575
Related Party [Member]    
Current Liabilities    
Accrued expenses- related party 981,119 938,774
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,743,558 1,731,058
Convertible notes payable 173,192 173,192
Notes payable - related party - net of debt discount of $0 and $0 as of March 31, 2025 and December 31, 2024 106,850 106,850
Nonrelated Party [Member]    
Current Liabilities    
Convertible notes payable $ 25,000 $ 25,000

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL